Tina S. Nova
Board Member
Aurinia Pharmaceuticals Inc. (AUPH)Equibles does not estimate personal net worth.
About Tina S. Nova
Tina S. Nova is recorded as Board Member at Aurinia Pharmaceuticals Inc. (AUPH). The newest filing on record that lists Tina S. Nova as Board Member at Aurinia Pharmaceuticals Inc. (AUPH) is dated April 21, 2026. Aurinia Pharmaceuticals Inc. reported in an 8-K filed May 15, 2025 that Tina S. Nova was appointed members of the Company's board of directors, effective May 15, 2025. Aurinia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aurinia Pharmaceuticals Inc. includes Jeffrey Bailey (CEO and Board Member), Kevin Tang (CEO and Board Member), Peter Greenleaf (CEO and Board Member) and 7 others.
“the shareholders elected Mr. Kevin Tang, Mr. Jeffrey A. Bailey, Ms. Kathy L. Goetz, Mr. Peter Greenleaf, Mr. Craig Johnson and Ms. Tina S. Nova to serve as members of the Company's board of directors until the annual general meeting of shareholders to be held in 2026.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 21, 2026
Company network
Leadership on record at Aurinia Pharmaceuticals Inc.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Michael Hearne CFO
- Matthew Donley COO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Karen Smith Board Member